C
Newsroom
CD Bioparticles
About
<p>CD Bioparticles specializes in manufacturing and supplying nanoparticles, microparticles, and coatings for diagnostics and research, alongside developing customized, biocompatible drug delivery systems. We offer diverse formulation technologies (from liposomes to polymer nanoparticles) and comprehensive services, including surface functionalization, antibody immobilization, and contract research for drug delivery.</p>
Press Releases
CD Bioparticles Announces Comprehensive AAV Vector Design Services to Advance Gene Therapy Research
Released on July 21, 2025
CD Bioparticles Launches Beads Based Multiplex Assay for High-Throughput Biomarker Detection
Released on July 21, 2025
CD Bioparticles Launches Purified Exosomes for Drug Delivery and Therapeutic Research
Released on July 2, 2025
CD Bioparticles Launches Advanced Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles for Targeted Cancer Therapy
Released on June 21, 2025
CD Bioparticles Announces Comprehensive Suite of Exosome Modification Products to Advance Research
Released on May 27, 2025
CD Bioparticles Launches Custom Nucleic Acid Delivery Particle Synthesis Services to Accelerate Gene Therapy and Research
Released on May 27, 2025
Newsroom powered by PR Underground.